Transparent communication, reliable reporting and long-term value creation for our shareholders, investors and the financial community.
We are currently preparing our Investor Relations section.
Please check back soon for updates and information.
Fresh Inset develops patented technologies based on 1-MCP, a compound sometimes called the “penicillin of agriculture” for its ability to delay ripening and extend produce freshness. The Company offers two complementary product lines. MaTri enables customers to dose, apply and verify 1-MCP treatments on-site, typically within 24 hours. Vidre+ delivers controlled 1-MCP release for up to 30 hours through stickers, labels, films and liners integrated into existing packaging processes, extending its use beyond conventional sealed storage facilities. Fresh Inset operates an in-house printing line, has a manufacturing agreement with Avery Dennison, and holds 20 granted patents and product registrations across the EU, US and Latin America. Vidre+ has been tested on more than 20 crops, with treatment costs typically representing 0.5–2.5% of the protected produce’s value. Based on the Company’s economic model and customer trial results, estimated net ROI is approximately 800% for producers, 1,200% for wholesalers and 650% for retailers.
Main target markets: Functional Packaging USD 35 B (2025); Post-Harvest Market USD 11 B (2024) Fresh Inset positions itself as a technology provider extending the use of 1-MCP beyond traditional sealed storage facilities to critical points across the fresh produce and floral value chain. The Company commercialises its solutions through established industry partners with direct access to end customers. Its strategy targets three application segments: storage, an established market where Fresh Inset aims to gain market share; logistics, identified by the Management Board as the primary short- to medium-term growth driver; and retail packaging, representing the largest long-term market opportunity. This progression increases the potential number of revenue-generating applications, from treatments per storage chamber to active labels per carton and individual consumer pack. In H1 2026, revenue reached approximately PLN 5.4 million, with the US accounting for 65% of sales. Approximately 74% of revenue came from customers who had also purchased in 2025, indicating repeat business. For 2026–2027, Fresh Inset is prioritising selected crops in the US, floral applications in Latin America and Europe, and the expansion of functional packaging distribution across European markets.
Fresh Inset unlocks 1-MCP, a substance proven for over 20 years and registered in more than 70 countries, so that it works in transport, and every packaging format through its MaTri and Vidre+ platforms, protecting products. The Management Board sees growth in moving along the chain from storage to logistics and retail packaging, across 5 continents. The Group is protected by 20 granted patents, registrations in the EU, the US and Latin America and a GMP production system, and it scales with partners such as Avery Dennison, Decco Postharvest and a global flower-care leader that will distribute exclusively from 2027. Early traction is visible in first-half 2026 revenue of about PLN 5.4 million, 4.2 times the previous year, with 74% coming from returning customers.
VIDRE+® is Fresh Inset’s patented post-harvest technology designed to extend the freshness and shelf life of fresh produce through the controlled release of 1-MCP directly inside product packaging.
Up to 1200%
Estimated net ROI for clients based on the Company’s economic model and customer trial results.
Technology Platform
Every Crop. Every Packaging Format. Extends freshness from farm to shelf.
Whether you’re exploring a pilot program or partnership opportunity, our team is ready to help.
Call Center
+48 983 120 650Our Location
Wileńska 4 / A017 Street
87-100 Toruń, Poland
Social Media
Let's Start the Conversation
Tell us about your needs, and we'll help find the right freshness solution.